📰 2 sources covering this story

Novo CEO says obesity market won't be winner-take-all battle with Lilly

First covered 3 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Novo CEO says obesity market won't be winner-take-all battle with Lilly
Reuters
Reuters1 hrs ago
Novo CEO says obesity market won't be winner-take-all battle with Lilly
Novo CEO says obesity market won't be winner-take-all battle with Lilly  Reuters
CTV News
CTV News🏁 first to report3 hrs ago
Novo CEO says obesity market won’t be winner-take-all battle with Lilly
Novo Nordisk CEO Mike Doustdar said investors are underestimating the demand for differentiation among obesity drugs, and that new treatment options like pills will keep it from becoming a winner-take-all battle with rival Eli Lilly.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →